Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract #4433: The effects of EGFR activation and attenuation of the TGF\#946; pathway in an orthotopic model of colon cancer

Melanie Ongchin, Elizabeth Sharratt, Ivan Dominguez, Jing Wang, Richard Cheney, Charles LeVea, Michael Brattain, Ashwani Rajput

Cancer Res (2009) 69 (9_Supplement): 4433.

Published: 01 May 2009

View article titled, Abstract #4433: The effects of EGFR activation and attenuation of the TGF\#946; pathway in an orthotopic model of colon cancer

Journal Articles

Abstract #LB-209: The HDAC inhibitor belinostat downregulates survivin in the FET colon cancer cell line by a TGF\#946; signaling dependent mechanism

Sanjib Chowdhury, Michael Brattain, Gillian Howell

Cancer Res (2009) 69 (9_Supplement): LB-209.

Published: 01 May 2009

View article titled, Abstract #LB-209: The HDAC inhibitor belinostat downregulates survivin in the FET colon cancer cell line by a TGF\#946; signaling dependent mechanism

Journal Articles

Abstract #4230: Ablation of Sp1 binding to survivin core promoter (-149 to -68) by the survivin expression inhibitor YM155 is potentially involved in YM155 inhibition of survivin gene transcription

Qiuying Cheng, Xiang Ling, Jianguo Wu, Takahito Nakahara, Kentaro Yamanaka, Masahiro Takeuchi, Michael Brattain, Fengzhi Li

Cancer Res (2009) 69 (9_Supplement): 4230.

Published: 01 May 2009

View article titled, Abstract #4230: Ablation of Sp1 binding to survivin core promoter (-149 to -68) by the survivin expression inhibitor YM155 is potentially involved in YM155 inhibition of survivin gene transcription

Journal Articles

The novel small chemical molecule YM155 is a bona fide survivin transcription inhibitor and acts on the survivin proximal promoter region: Inhibition of survivin promoter activity by YM155 is cell cycle-independent

Qiuying Cheng, Xiang Ling, Jianguo Wu, Takahito Nakahara, Kentaro Yamanaka, Masahiro Takeuchi, Michael Brattain, Fengzhi Li

Cancer Res (2008) 68 (9_Supplement): 1848.

Published: 01 May 2008

View article titled, The novel small chemical molecule YM155 is a bona fide survivin transcription inhibitor and acts on the survivin proximal promoter region: Inhibition of survivin promoter activity by YM155 is cell cycle-independent

Journal Articles

IGF1R mediated activation of the autocrine TGFα loop requires the PI3K pathway but not the MAPK pathway

Sandip Patil, Yi Hu, Michelle Vinci, Wenhui Li, Jennie Hauser, Lisa Humphrey, Michael Brattain

Cancer Res (2007) 67 (9_Supplement): 3576.

Published: 01 May 2007

View article titled, IGF1R mediated activation of the autocrine TGFα loop requires the PI3K pathway but not the MAPK pathway

Journal Articles

TGF-β/RON axis in the progression of pancreatic cancer

James Freeman, Sudhakar Ammanamanchi, Shujie Zhao, Michael Brattain, Jing Wang, Venkatasubbarao Kolaparthi

Cancer Res (2007) 67 (9_Supplement): 3777.

Published: 01 May 2007

View article titled, TGF-β/RON axis in the progression of pancreatic cancer

Journal Articles

Inhibition of apoptosis leads to a metastatic phenotype in an orthotopic model of colon

ivan dominguez, Jing Wang, Charles LeVea, Rebecca Rose, Elizabeth Sharratt, Michael Brattain, Ashwani Rajput

Cancer Res (2007) 67 (9_Supplement): 5492.

Published: 01 May 2007

View article titled, Inhibition of apoptosis leads to a metastatic phenotype in an orthotopic model of colon

Journal Articles

Smad3 mediates TGF-beta induced apoptosis through the control of survivin expression

Dong-Weon Song, Jianguo Wu, Sudhakar Ammanamanchi, Junhua Yang, Jennie Hauser, Fengzhi Li, Michael Brattain

Cancer Res (2005) 65 (9_Supplement): 1064.

Published: 01 May 2005

View article titled, Smad3 mediates TGF-beta induced apoptosis through the control of survivin expression

Journal Articles

TGF-β signaling pathway communicates with the p38 MAP kinase pathway.

Dong-Weon Song, Michael Brattain

Cancer Res (2004) 64 (7_Supplement): 800.

Published: 01 April 2004

View article titled, TGF-β signaling pathway communicates with the p38 MAP kinase pathway.

Journal Articles

Increased Growth of NIH/3T3 Cells by Transfection with Human p120 Complementary DNA and Inhibition by a p120 Antisense Construct

Laszlo Perlaky, Benigno C. Valdez, Rose K. Busch, Robert G. Larson, Sissy M. Jhiang, Wei Wei Zhang, Michael Brattain, Harris Busch

Cancer Res (1992) 52 (2): 428–436.

Published: 01 January 1992

View article titled, Increased Growth of NIH/3T3 Cells by Transfection with Human p120 Complementary DNA and Inhibition by a p120 Antisense Construct

Journal Articles

Determination of the Effects of Epidermal Growth Factor on Urokinase Secretion and Urokinase Receptor Display in a Well-Differentiated Human Colon Carcinoma Cell Line

Douglas Boyd, Michael Brattain

Cancer Res (1989) 49 (8): 1948–1953.

Published: 01 April 1989

View article titled, Determination of the Effects of Epidermal Growth Factor on Urokinase Secretion and Urokinase Receptor Display in a Well-Differentiated Human Colon Carcinoma Cell Line

Journal Articles

Examination of Urokinase Protein/Transcript Levels and Their Relationship with Laminin Degradation in Cultured Colon Carcinoma

Douglas Boyd, Barry Ziober, Subhas Chakrabarty, Michael Brattain

Cancer Res (1989) 49 (4): 816–820.

Published: 01 February 1989

View article titled, Examination of Urokinase Protein/Transcript Levels and Their Relationship with Laminin Degradation in Cultured Colon Carcinoma

Journal Articles

Determination of the Levels of Urokinase and Its Receptor in Human Colon Carcinoma Cell Lines

Douglas Boyd, Germaine Florent, Paul Kim, Michael Brattain

Cancer Res (1988) 48 (11): 3112–3116.

Published: 01 June 1988

View article titled, Determination of the Levels of Urokinase and Its Receptor in Human Colon Carcinoma Cell Lines

NARROW

Abstract #4433: The effects of EGFR activation and attenuation of the TGF\#946; pathway in an orthotopic model of colon cancer

Abstract #LB-209: The HDAC inhibitor belinostat downregulates survivin in the FET colon cancer cell line by a TGF\#946; signaling dependent mechanism

Abstract #4230: Ablation of Sp1 binding to survivin core promoter (-149 to -68) by the survivin expression inhibitor YM155 is potentially involved in YM155 inhibition of survivin gene transcription

The novel small chemical molecule YM155 is a bona fide survivin transcription inhibitor and acts on the survivin proximal promoter region: Inhibition of survivin promoter activity by YM155 is cell cycle-independent

IGF1R mediated activation of the autocrine TGFα loop requires the PI3K pathway but not the MAPK pathway

TGF-β/RON axis in the progression of pancreatic cancer

Inhibition of apoptosis leads to a metastatic phenotype in an orthotopic model of colon

Smad3 mediates TGF-beta induced apoptosis through the control of survivin expression

TGF-β signaling pathway communicates with the p38 MAP kinase pathway.

Increased Growth of NIH/3T3 Cells by Transfection with Human p120 Complementary DNA and Inhibition by a p120 Antisense Construct

Determination of the Effects of Epidermal Growth Factor on Urokinase Secretion and Urokinase Receptor Display in a Well-Differentiated Human Colon Carcinoma Cell Line

Examination of Urokinase Protein/Transcript Levels and Their Relationship with Laminin Degradation in Cultured Colon Carcinoma

Determination of the Levels of Urokinase and Its Receptor in Human Colon Carcinoma Cell Lines

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only